| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |